A carregar...
Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model.
The bleeding disorder of hemophilia A currently treated by replacement therapy of the missing coagulation factor, factor VIII, is frequently complicated by the development of neutralizing antibodies. The therapeutic potential of attenuated forms of the lipid-associated glycoprotein tissue factor, a...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
1988
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303495/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3134399/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113571 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|